❌

Normal view

Received — 26 March 2026 ⏭

Oncogene - Issue - nature.com science feeds
TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation Xi Wang · Guangyan Li · Jiaming Wu · Baiyang Fu · Haoyang Zhang · Yichi Chen · Jianjiao Wang · Jianguo Zhang · Xi Chen
Oncogene, Published online: 24 March 2026; doi:10.1038/s41388-026-03728-6TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation
24 March 2026 at 08:00

TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation

Oncogene - Issue - nature.com science feeds

By: Xi Wang · Guangyan Li · Jiaming Wu · Baiyang Fu · Haoyang Zhang · Yichi Chen · Jianjiao Wang · Jianguo Zhang · Xi Chen

24 March 2026 at 08:00

Oncogene, Published online: 24 March 2026; doi:10.1038/s41388-026-03728-6

TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation